This International Immunosuppression Summit 2016 will bring together scientists to discuss the problems associated with natural and induced immunosuppression.
A late registration fee applies after January 20th 2016
Who should attend
This summit will interest those working in drug design and discovery, physicians and clinicians, research scientists and academics, and those who work within the industry.
This event has an open abstract session.
Abstracts can be submitted on any subject related to Immunosuppression and Immunotherapy.
The Deadline for abstract submissions for oral presentation is December 10th 2015
Abstracts for poster presentation only can be submitted up to two weeks before the event You can download the instructions for authors at www.euroscicon.com/ABSTRACTSUBMISSIONS.pdf
The COVID-19 pandemic has laid bare some of healthcare's most entrenched limitations, including a reliance on in-person visits, staffing shortages and a tendency to exclude IT from conversations about the organization's overall goals. During Becker’s Hospital Review’s 12th Annual Meeting, in a session sponsored by IBM Watson Health, three company leaders — Steve Vance, […]